Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: A long-term survival analysis

European Urology

Volumn 63, Issue 6, 2013, Pages 998-1008

  Abdollah, Firas ^a   Suardi, Nazareno ^a   Cozzarini, Cesare ^a   Gallina, Andrea ^a   Capitanio, Umberto ^a   Bianchi, Marco ^a   Sun, Maxine ^b   Fossati, Nicola ^a   Passoni, Niccolò Maria ^a   Fiorino, Claudio ^a   Di Muzio, Nadia ^a   Karakiewicz, Pierre I ^b   Rigatti, Patrizio ^a   Montorsi, Francesco ^a   Briganti, Alberto ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Adjuvant; Neoplasm recurrence; Prostatic neoplasms mortality; Prostatic neoplasms pathology; Prostatic neoplasms surgery; Radiotherapy; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; GLEASON SCORE; HUMAN; LONG TERM SURVIVAL; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RISK FACTOR; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM STAGING; PATIENT SELECTION; PELVIS; PROPORTIONAL HAZARDS MODELS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84876483001     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.10.036     Document Type: Article

References (22)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. M.M. Center, A. Jemal, and J. Lortet-Tieulent International variation in prostate cancer incidence and mortality rates Eur Urol 61 2012 1079 1092
3. Y.H. Shao, K. Demissie, and W. Shih Contemporary risk profile of prostate cancer in the United States J Natl Cancer Inst 101 2009 1280 1283
4. F. Abdollah, M. Sun, and R. Thuret Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer Eur Urol 58 2010 882 892
5. L. Budaus, H. Isbarn, and C. Eichelberg Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage J Urol 184 2010 1341 1346
6. M. Bolla, H. van Poppel, and L. Collette Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) Lancet 366 2005 572 578
7. I.M. Thompson Jr., C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial JAMA 296 2006 2329 2335
8. T. Wiegel, D. Bottke, and U. Steiner Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 2009 2924 2930
9. H. Van Poppel, M. Bolla, and B. Tombal Adjuvant radiotherapy after radical prostatectomy in patients with pathologically high risk prostate cancer: 10-year follow-up results Eur Urol Suppl 10 2011 93
10. I.M. Thompson, C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial J Urol 181 2009 956 962
11. NCCN Clinical Practice Guidelines in Oncology 2011. Prostate cancer. National Comprehensive Cancer Network Web site. http://www.nccn.org/ professionals/physician-gls/pdf/prostate.pdf. Accessed June 6, 2011.
12. J.E. McNeal, E.A. Redwine, F.S. Freiha, and T.A. Stamey Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread Am J Surg Pathol 12 1988 897 906
13. C. Cozzarini, F. Montorsi, and C. Fiorino Need for high radiation dose (>or = 70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients Int J Radiat Oncol Biol Phys 75 2009 966 974
14. F. Harrell, K. Lee, and D. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
15. F.E. Harrell Jr., R.M. Califf, D.B. Pryor, K.L. Lee, and R.A. Rosati Evaluating the yield of medical tests JAMA 247 1982 2543 2546
16. M.W. Kattan, J.A. Eastham, A.M. Stapleton, T.M. Wheeler, and P.T. Scardino A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer J Natl Cancer Inst 90 1998 766 771
17. A. Briganti, J.R. Karnes, and L.F. Da Pozzo Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy Eur Urol 55 2009 261 270
18. M.C. Schumacher, F.C. Burkhard, G.N. Thalmann, A. Fleischmann, and U.E. Studer Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy Eur Urol 54 2008 344 352
19. A. Briganti, R.J. Karnes, and L.F. Da Pozzo Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis Eur Urol 59 2011 832 840
20. C. Parker, N. Clarke, and J. Logue RADICALS (Radiotherapy and Androgen Deprivation in Combination after Local Surgery) Clin Oncol (R Coll Radiol) 19 2007 167 171
21. C. Parker, M.R. Sydes, and C. Catton Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): a new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy BJU international 99 2007 1376 1379
22. A. Briganti, T. Wiegel, and S. Joniau Early salvage radiation therapy does not compromise cancer control in patients with pt3n0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis Eur Urol 62 2012 472 487